As the market reopened following the long July 4 weekend, Cathie Wood-run Ark Invest made some portfolio moves, notable among which is the offloading of a huge chunk of Stratasys Ltd. (NASDAQ:SSYS) stake.
Stratasys is a 3D printing company that specializes in the process of creating physical objects from digital designs. It serves a wide range of industries, including aerospace, automotive, consumer product, and healthcare.
Ark's flagship fund — ARK Innovation ETF (NYSE:ARKK) — sold 1.844 million Stratasys shares on Tuesday, and the ARK Autonomous Technology & Robotics ETF (BATS:ARKQ) divested 40,805 shares.
At Stratasys's closing price of $19.02 on Tuesday, the disposals would have fetched Ark $35.84 million.
Related Link: Cathie Wood Sees This Technology Accelerating GDP Growth To 50% Per Year
Other Major Portfolio Changes:
- ARKK bought 20,837 shares of cloud communication software company Twilio, Inc. (NASDAQ:TWLO) and 6,905 shares of cryptocurrency exchange Coinbase Global, Inc. (NASDAQ:COIN).
- ARKK sold 93,793 shares of cell biology company Berkeley Lights, Inc. (NASDAQ:BLI).
- ARK's ARK Genomic Revolution ETF (BATS:ARKG) picked up 108,500 shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX), 437,372 shares of Surface Oncology, Inc. (NASDAQ:SURF) and 100,317 shares of Atai Life Sciences NV (NASDAQ:ATAI). It trimmed its position in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) by 164,632 shares.
Price Action: ARKK closed Tuesday's session 9.10% higher at $44.97, according to Benzinga Pro data.
